| Literature DB >> 25093025 |
Chia-I Tsai1, Yi-Chang Su2, Shih-Yi Lin3, I-Te Lee4, Cheng-Hung Lee2, Tsai-Chung Li5.
Abstract
Aim. To evaluate how health-related quality of life (HRQOL) and traditional Chinese medicine (TCM) constitutions of Yin-Xu, Yang-Xu, and Stasis are related in type 2 diabetes patients. Method. Seven hundred and five subjects were recruited in 2010 for this study from a Diabetes Shared Care Network in Taiwan. Generic and disease-specific HRQOL were assessed by the short form 36 (SF-36) and the diabetes impact measurement scale (DIMS). Constitutions of Yin-Xu, Yang-Xu, and Stasis were then assessed by the body constitution questionnaire (BCQ), a questionnaire consisting of 44 items that evaluate the physiological state based on subjective symptoms and signs. Results. Estimated effects of the Ying-Xu and Stasis on all scales of the SF-36 were significantly negative, while estimated effects of the Yang-Xu on all scales (except for SF, RE, MH, and MCS) were significantly negative. For DIMS, the estimated effects of the Ying-Xu and Stasis on all scales were significantly negative except for Stasis on well-being, while Yang-Xu has a significantly negative effect only on symptoms. Conclusions. This study demonstrates that TCM constitutions of Yin-Xu, Yang-Xu, and Stasis are closely related to a reduction in HRQOL. These findings support the need for further research into the impact of intervention for TCM constitutions on HRQOL in patients with type 2 diabetes.Entities:
Year: 2014 PMID: 25093025 PMCID: PMC4100449 DOI: 10.1155/2014/309403
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Comparisons of basic characteristics between constitutions of Yin-Xu, Yang-Xu, and Stasis.
| Variable | Total ( |
Yin-Xu ( |
Yang-Xu ( |
Stasis ( | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| No ( | Yes ( |
| No ( | Yes ( |
| No ( | Yes ( |
| ||
| Gender | ||||||||||
| Male, | 405 (57.5%) | 304 (43.1%) | 101 (14.3%) | 0.05 | 369 (52.3%) | 36 (5.11%) | 0.00∗∗ | 364 (51.6%) | 41 (5.82%) | 0.01∗ |
| Age (yr) | 63.90 ± 13.35 | 63.24 ± 13.24 | 65.61 ± 13.53 | 0.04∗ | 63.97 ± 13.21 | 63.45 ± 14.36 | 0.72 | 63.79 ± 13.29 | 64.69 ± 13.81 | 0.58 |
| BMI (kg/m2) | 25.46 ± 4.01 | 25.46 ± 4.15 | 25.46 ± 3.63 | 0.97 | 25.43 ± 3.99 | 25.67 ± 4.13 | 0.59 | 25.32 ± 3.98 | 26.45 ± 4.05 | 0.01∗ |
| Duration of diabetes (years) | 9.03 ± 8.12 | 8.74 ± 7.69 | 9.78 ± 9.14 | 0.15 | 8.86 ± 7.81 | 10.16 ± 9.95 | 0.21 | 9.05 ± 8.04 | 8.87 ± 8.72 | 0.78 |
| Waist (cm) | 89.10 ± 10.65 | 89.33 ± 10.88 | 88.52 ± 10.02 | 0.40 | 89.17 ± 10.48 | 88.63 ± 11.76 | 0.66 | 88.67 ± 10.44 | 92.07 ± 11.56 | 0.01∗ |
| Smoking | 0.87 | 0.88 | 0.13 | |||||||
| No | 691 (98.01%) | 499 (70.78%) | 192 (27.23%) | 602 (85.39%) | 89 (12.62%) | 605 (85.82%) | 86 (12.20%) | |||
| Sometimes | 9 (1.28%) | 6 (0.85%) | 3 (0.43%) | 8 (1.13%) | 1 (0.14%) | 7 (0.99%) | 2 (0.28%) | |||
| Usually | 5 (0.71%) | 4 (0.57%) | 1 (0.14%) | 4 (0.57%) | 1 (0.14%) | 3 (0.43%) | 2 (0.28%) | |||
| Physical activity | 0.09 | 0.02∗ | 0.004∗∗ | |||||||
| No | 149 (21.19%) | 98 (13.94%) | 51 (7.25%) | 123 (17.50%) | 26 (3.70%) | 118 (16.79%) | 31 (4.41%) | |||
| Sometimes | 197 (28.02%) | 138 (19.63%) | 59 (8.39%) | 164 (23.33%) | 33 (4.69%) | 170 (24.18%) | 27 (3.84%) | |||
| Usually | 357 (50.79%) | 271 (38.55%) | 86 (12.23%) | 325 (46.23%) | 32 (4.55%) | 325 (46.23%) | 32 (4.55%) | |||
| GFR (mL/min) | 67.37 ± 22.11 | 68.73 ± 21.44 | 63.91 ± 23.43 | 0.03∗ | 67.62 ± 21.12 | 65.75 ± 27.85 | 0.38 | 67.52 ± 21.38 | 66.35 ± 26.78 | 0.82 |
| Microalbumin (mg/dL) | 21.96 ± 69.64 | 19.42 ± 59.95 | 28.40 ± 89.47 | 0.19 | 20.86 ± 67.13 | 29.84 ± 87.44 | 0.41 | 20.81 ± 66.62 | 30.05 ± 87.98 | 0.34 |
| Fasting glucose (mg/dL) | 142.98 ± 48.20 | 142.34 ± 44.75 | 144.62 ± 56.17 | 0.51 | 141.82 ± 45.28 | 150.73 ± 64.15 | 0.18 | 142.14 ± 47.84 | 148.73 ± 50.54 | 0.15 |
| HbA1c (%) | 7.65 ± 1.58 | 7.59 ± 1.52 | 7.80 ± 1.71 | 0.11 | 7.61 ± 1.56 | 7.92 ± 1.70 | 0.08 | 7.58 ± 1.56 | 8.10 ± 1.66 | 0.004∗∗ |
| Triglycerides (mg/dL) | 151.99 ± 170.80 | 154.82 ± 195.41 | 144.80 ± 79.36 | 0.36 | 151.28 ± 177.51 | 156.68 ± 117.94 | 0.73 | 155.89 ± 177.56 | 152.66 ± 115.79 | 0.99 |
| HDL-C (mg/dL) | 52.02 ± 14.10 | 52.31 ± 14.44 | 51.26 ± 13.20 | 0.61 | 52.14 ± 14.24 | 51.18 ± 13.18 | 0.53 | 52.13 ± 14.16 | 51.20 ± 13.71 | 0.85 |
| LDL-C (mg/dL) | 106.26 ± 31.33 | 105.39 ± 30.23 | 108.52 ± 34.04 | 0.39 | 105.90 ± 31.43 | 108.76 ± 30.75 | 0.31 | 105.26 ± 30.73 | 113.58 ± 34.79 | 0.04∗ |
| SBP (mmHg) | 131.35 ± 14.67 | 131.38 ± 14.56 | 131.30 ± 14.97 | 0.98 | 131.50 ± 14.37 | 130.38 ± 16.61 | 0.49 | 131.24 ± 14.52 | 132.13 ± 15.74 | 0.54 |
| DBP (mmHg) | 77.53 ± 9.21 | 77.67 ± 9.06 | 77.18 ± 9.59 | 0.56 | 77.43 ± 9.02 | 78.24 ± 10.43 | 0.47 | 77.62 ± 9.11 | 76.90 ± 9.87 | 0.55 |
Data were presented as mean ± SD; *P < 0.05, **P < 0.01.
BMI: body mass index; GPT: glutamic pyruvic transaminase; GFR: glomerular filtration rate; HbA1c: glycosylated hemoglobin; HDL: high density lipoprotein; LDL: low density lipoprotein; SBP: systolic blood pressure; DBP: diastolic blood pressure.
Comparisons of domains of SF-36 and DIMS between constitutions of Yin-Xu, Yang-Xu, and Stasis#.
| Variable | Yin-Xu |
| Yang-Xu |
| Stasis |
| |||
|---|---|---|---|---|---|---|---|---|---|
| No ( | Yes ( | No ( | Yes ( | No ( | Yes ( | ||||
| SF36 | |||||||||
| PF | 82.25 ± 18.07 | 69.44 ± 23.00 | 49.14∗∗∗ | 80.89 ± 18.83 | 63.85 ± 24.01 | 41.99∗∗∗ | 80.90 ± 18.92 | 63.61 ± 23.45 | 44.62∗∗∗ |
| RP | 74.51 ± 34.61 | 52.55 ± 42.06 | 42.38∗∗∗ | 71.90 ± 36.05 | 44.78 ± 43.06 | 32.72∗∗∗ | 72.72 ± 35.77 | 38.89 ± 40.56 | 67.73∗∗∗ |
| BP | 83.46 ± 19.28 | 68.71 ± 22.92 | 63.84∗∗∗ | 81.68 ± 20.09 | 63.71 ± 23.41 | 48.30∗∗∗ | 81.84 ± 20.38 | 62.39 ± 20.54 | 71.40∗∗∗ |
| GH | 58.69 ± 20.75 | 43.18 ± 23.41 | 66.10∗∗∗ | 56.74 ± 21.73 | 38.42 ± 21.99 | 56.10∗∗∗ | 57.19 ± 21.39 | 35.12 ± 21.29 | 83.72∗∗∗ |
| VT | 59.56 ± 11.44 | 52.04 ± 12.33 | 58.37∗∗∗ | 58.77 ± 11.66 | 48.68 ± 11.88 | 58.98∗∗∗ | 59.10 ± 11.42 | 46.28 ± 11.18 | 99.60∗∗∗ |
| SF | 82.63 ± 18.85 | 72.13 ± 23.46 | 31.47∗∗∗ | 81.50 ± 19.81 | 67.58 ± 22.97 | 30.14∗∗∗ | 82.04 ± 19.06 | 63.75 ± 24.65 | 45.56∗∗∗ |
| RE | 94.42 ± 17.69 | 81.29 ± 32.05 | 29.48∗∗∗ | 92.66 ± 20.84 | 78.02 ± 33.41 | 16.48∗∗ | 93.11 ± 20.00 | 74.81 ± 35.44 | 22.94∗∗∗ |
| MH | 74.47 ± 10.77 | 68.59 ± 15.25 | 24.40∗∗∗ | 73.97 ± 11.83 | 65.19 ± 13.86 | 32.95∗∗∗ | 74.20 ± 11.51 | 63.56 ± 14.61 | 43.82∗∗∗ |
| PCS | 47.55 ± 9.21 | 40.40 ± 11.10 | 64.32∗∗∗ | 46.70 ± 9.58 | 37.87 ± 11.46 | 48.86∗∗∗ | 46.82 ± 9.52 | 37.00 ± 11.14 | 63.20∗∗∗ |
| MCS | 51.59 ± 6.28 | 48.97 ± 8.69 | 14.59∗∗ | 51.32 ± 6.84 | 47.80 ± 8.23 | 15.05∗∗ | 51.50 ± 6.56 | 46.53 ± 9.13 | 24.80∗∗∗ |
| DIMS | |||||||||
| Scale 1 | 49.22 ± 4.84 | 43.06 ± 4.94 | 226.80∗∗∗ | 48.34 ± 5.16 | 41.90 ± 5.21 | 122.99∗∗∗ | 48.32 ± 5.23 | 41.97 ± 4.83 | 117.94∗∗∗ |
| Scale 2 | 25.78 ± 4.03 | 22.71 ± 4.75 | 63.84∗∗∗ | 25.36 ± 4.23 | 21.97 ± 4.78 | 49.28∗∗∗ | 25.47 ± 4.14 | 21.18 ± 4.72 | 81.36∗∗∗ |
| Scale 3 | 33.70 ± 4.21 | 31.99 ± 4.58 | 22.18∗∗∗ | 33.44 ± 4.32 | 31.78 ± 4.54 | 11.49∗∗ | 33.61 ± 4.24 | 30.61 ± 4.47 | 38.69∗∗∗ |
| Scale 4 | 13.59 ± 3.42 | 12.02 ± 3.89 | 24.70∗∗∗ | 13.31 ± 3.58 | 12.07 ± 3.78 | 9.49∗ | 13.45 ± 3.50 | 11.12 ± 3.82 | 33.87∗∗∗ |
#Data were presented as mean ± SD; *P < 0.05; **P < 0.01; ***P < 0.001.
PF: physical function, RP: role physical, BP: bodily pain, GH: general health, VT: vitality, SF: social functioning, RE: role emotional, MH: mental health, PCS: physical component summary, and MCS: mental component summary.
DIMS: diabetes impact measurement scale, scale 1: symptoms, scale 2: diabetes-related morale, scale 3: social role fulfillment, and scale 4: well-being.
The adjusted regression coefficients of Yin-Xu, Yang-Xu, and Stasis on health-related quality of life measured by SF-36#.
| Variable | PF | RP | BP | GH | VT | |||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| Standardized |
| Standardized |
| Standardized |
| Standardized |
| Standardized | |
| Yin-Xu | ||||||||||
| Yes | −4.86 (1.58)∗∗ | −0.11 | −9.97 (3.38)∗∗ | −0.12 | −7.47 (1.90)∗∗∗ | −0.16 | −8.37 (2.02)∗∗∗ | −0.17 | −3.32 (1.09)∗∗ | −0.12 |
| Yang-Xu | ||||||||||
| Yes | −8.38 (2.19)∗∗∗ | −0.14 | −9.57 (4.69)∗ | −0.09 | −6.30 (2.64)∗ | −0.10 | −5.70 (2.80)∗ | −0.08 | −3.58 (1.51)∗ | −0.10 |
| Stasis | ||||||||||
| Yes | −5.69 (2.23)∗ | −0.09 | −15.26 (4.76)∗∗ | −0.13 | −8.00 (2.68)∗∗ | −0.12 | −11.32 (2.84)∗∗∗ | −0.16 | −7.94 (1.54)∗∗∗ | −0.21 |
|
| 41% | 23% | 25% | 24% | 24% | |||||
|
| ||||||||||
| SF | RE | MH | PCS | MCS | ||||||
|
| Standardized |
| Standardized |
| Standardized |
| Standardized |
| Standardized | |
|
| ||||||||||
| Yin-Xu | ||||||||||
| Yes | −3.82 (1.91)∗ | −0.08 | −8.45 (2.15)∗∗∗ | −0.17 | −2.49 (1.12)∗ | −0.09 | −3.22 (0.83)∗∗∗ | −0.14 | −1.39 (0.64)∗ | −0.09 |
| Yang-Xu | ||||||||||
| Yes | −4.79 (2.65) | −0.08 | −2.15 (2.97) | −0.03 | −2.04 (1.55) | −0.06 | −3.76 (1.15)∗ | −0.12 | −0.32 (0.89) | −0.02 |
| Stasis | ||||||||||
| Yes | −11.23 (2.69)∗∗∗ | −0.18 | −11.16 (3.02)∗∗ | −0.16 | −8.24 (1.57)∗∗∗ | −0.22 | −3.53 (1.17)∗ | −0.11 | −4.39 (0.90)∗∗∗ | −0.20 |
|
| 20% | 16% | 23% | 35% | 22% | |||||
(1) #Parameter estimates (SE), *P < 0.05;**P < 0.01; ***P < 0.001.
(2) Parameter estimates were from multiple linear regression adjusting for age, height, weight, smoking, regular exercise, fasting glucose, duration of diabetes, glycosylated hemoglobin, triglycerides, GPT, LDL-C, creatinine, GFR, diabetic neuropathy, diabetic retinopathy, metabolic syndrome, and comorbidity.
(3) PF: physical function, RP: role physical, BP: bodily pain, GH: general health, VT: vitality, SF: social functioning, RE: role emotional, MH: mental health, PCS: physical component summary, and MCS: mental component summary.
The adjusted regression coefficients of Yin-Xu, Yang-Xu, and Stasis on diabetics with the quality of life measured by diabetes impact measurement scales#.
| Variable | Symptoms | Related morale | Social role | Well-being | ||||
|---|---|---|---|---|---|---|---|---|
|
| Standardized |
| Standardized |
| Standardized |
| Standardized | |
| Yin-Xu (no as reference group) | ||||||||
| Yes | −4.00 (0.42)∗∗∗ | −0.32 | −1.63 (0.40)∗∗∗ | −0.16 | −0.88 (0.37)∗ | −0.09 | −0.85 (0.33)∗∗ | −0.11 |
| Yang-Xu (no as reference group) | ||||||||
| Yes | −2.58 (0.58)∗∗∗ | −0.15 | −0.76 (0.56) | −0.06 | −0.08 (0.52) | −0.01 | −0.35 (0.46) | 0.03 |
| Stasis (no as reference group) | ||||||||
| Yes | −2.34 (0.59)∗∗∗ | −0.14 | −2.97 (0.57)∗∗∗ | −0.22 | −1.65 (0.53)∗∗ | −0.12 | −1.71 (0.47) | −0.15 |
|
| 45% | 23% | 30% | 20% | ||||
(1) #Parameter estimates (SE).
(2) *P < 0.05; **P < 0.01; ***P < 0.001.
(3) Parameter estimates were from multiple linear regression adjusting for age, height, weight, smoking, physical activity, fasting glucose, duration of diabetes, glycosylated hemoglobin, triglycerides, GPT, LDL-C, creatinine, GFR, diabetic neuropathy, diabetic retinopathy, metabolic syndrome, and combined morbidity.